A total of 131 patients were enrolled at 19 leading wound care centers across the United States. Patients between 18 and 80 years of age with confirmed type 1 or type 2 diabetes and chronic diabetic ...

A partnership between Osiris Therapeutics and Net Health has broadened the availability of Grafix, a human placental tissue product used to treat chronic wounds. At present, Grafix is marketed by ...

Osiris Therapeutics, Inc. OSIR, reported today that its multi-center, randomized, controlled clinical trial comparing the safety and effectiveness of Grafix® to standard of care in patients with ...

(Reuters) - Shares of Osiris Therapeutics Inc rose 15 percent on Wednesday, after U.S. health regulators said the stem-cell technology company's wound treatment was eligible for reimbursement when ...